Back to Authors

Winthrop, K.L.

A5050439846 | I165690674

Mayo Clinic

Oregon Health & Science University

Citations 13

Racial, Ethnic, and Socioeconomic Disparities in Treatment and Outcomes of Patients with Bronchiectasis and Nontuberculous Mycobacteria (NTM)

TP32. TP032 EPIDEMIOLOGY, BIOMARKERS, AND THERAPY IN CF AND NON-CF BRONCHIECTASIS | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2013-A2013

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2013

Recommendations for Management of Nontuberculous Mycobacterial (NTM) in Lung Transplant Recipients: An International Delphi Study

TP96. TP096 CLINICAL AND BASIC SCIENCE DEVELOPMENTS IN NTM AND BRONCHIECTASIS | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A3945-A3945

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3945

The Validity of Claims-Based Codes to Identify Pseudomonas Infection in Patients with Bronchiectasis in Medicare Data

C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5697-A5697

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5697